1 Immune restoration disease after antiretroviral therapy

2 Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease

3 Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

4 The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3

5 Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

6 Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

7 Use of total lymphocyte count for monitoring response to antiretroviral therapy

8 Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis

9 Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy

10 demographical, viro-immunological, clinical and therapeutical characteristics of hiv infected patients in a “epidemiologically unexplored” region of italy (calabria region): the calabrhiv cohort.

11 Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy

12 Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children

13 Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

14 Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania

15 Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania

16 Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.

17 Consistent Condom Use and Associated Factors among HIV-Positive Clients on Antiretroviral Therapy in North West Ethiopian Health Center, 2016 GC

18 Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90 of HIV-Infected Individuals

19 The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa

20 The global magnitude of metabolic syndrome among antiretroviral therapy (ART) exposed and ART-naïve adult HIV-infected patients in gedio-zone, southern Ethiopia: Comparative cross-sectional study, using the Adult Treatment Panel III criteria.

21 Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIV-infected Persons.

22 EFFECT OF COMMUNITY TREATMENT INITIATIVE ON ANTIRETROVIRAL THERAPY UPTAKE AMONG LINKAGE - RESISTANT PLHIV IN NORTHERN NIGERIA.

23 Multisystem impairment in South African adolescents with Perinatally acquired HIV on antiretroviral therapy (ART).

24 Incidence and Risk Factors for Renal Disease in an Outpatient Cohort of HIV-Infected Patients on Antiretroviral Therapy.

25 Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: Predicted effect of using a single viral load to define efavirenz-based first-line failure

26 Impact of HIV-Status Disclosure on HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy

27 HIV, antiretroviral therapy and non-communicable diseases in sub-Saharan Africa: empirical evidence from 44 countries over the period 2000 to 2016

28 Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uganda.

29 Reconnaissance of the candidate genes involved in the pathogenesis of human immunodeficiency virus and targeted by antiretroviral therapy.

30 The association between a detectable HIV viral load and non-communicable diseases comorbidity in HIV positive adults on antiretroviral therapy in Western Cape, South Africa

31 Trends and predictors of non-communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil

32 Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.

33 Factors associated with antiretroviral therapy adherence in adults: An integrative review of literature

34 Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review.

35 Optimizing Antiretroviral Therapy in Treatment-Experienced Patients Living with HIV: A Critical Review of Switch and Simplification Strategies. An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy.

36 A Qualitative Study to Identify Perceptual Barriers to Antiretroviral Therapy (ART) Uptake and Adherence in HIV Positive People from UK Black African and Caribbean Communities.

37 Barriers and facilitators of antiretroviral therapy adherence in rural Eastern province, Zambia: the role of household economic status.

38 "If I have nothing to eat, I get angry and push the pills bottle away from me": A qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo.

39 Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study.

40 Assessing the Content Validity of a New Patient-Reported Measure of Barriers to Antiretroviral Therapy Adherence for Electronic Administration in Routine HIV Care: Proposal for a Web-Based Delphi Study.

41 [Comparative study on the effect of highly active antiretroviral therapy (HAART) in patients with HIV infection acquired by blood transfusion and paid plasma donation].

42 [Survival analysis on HIV/AIDS patients who began receiving antiretroviral therapy from 2005 to 2015 in Tianjin].

43 High Incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015.

44 A first-line antiretroviral therapy-resistant HIV patient with rhinoentomophthoromycosis.

45 Large transmission clusters of HIV-1 main genotypes among HIV-1 individuals before antiretroviral therapy in the Hebei province, China.

46 A comparison of adherence to antiretroviral therapy amongst adolescent patients of the Baylor International Pediatric AIDS Initiative Children’s Centers of Excellence before and after attendance at recreational therapy camp

47 DEMOGRAPHIC PROFILE OF HIV-POSITIVE PATIENTS REGISTERED AT ANTIRETROVIRAL THERAPY CENTRE HAYATABAD MEDICAL COMPLEX, PESHAWAR

48 Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.

49 The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.

50 CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy.

51 Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients

52 Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection

53 Same day HIV diagnosis and antiretroviral therapy initiation affects retention in Option B+ prevention of mother-to-child transmission services at antenatal care in Zomba District, Malawi.

54 WHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV-infected patients.

55 Convenience without disclosure: A formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania

56 Tuberculosis Preventive Treatment Scale-Up Among Antiretroviral Therapy Patients - 16 Countries Supported by the U.S. President's Emergency Plan for AIDS Relief, 2017-2019.

57 Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review

58 Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania.

59 Utilization of dual contraception method among reproductive age women on antiretroviral therapy in selected public hospitals of Northern Ethiopia.

60 Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.

61 Impact of universal antiretroviral therapy for pregnant and postpartum women on antiretroviral therapy uptake and retention.

62 The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era

63 Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial

64 Is Modern Antiretroviral Therapy Causing Weight Gain?

65 High Proportions of Patients With Advanced HIV Are Antiretroviral Therapy Experienced: Hospitalization Outcomes From 2 Sub-Saharan African Sites

66 Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy

67 Understanding the Role of HIV Load in Determining Weight Change in the Era of Highly Active Antiretroviral Therapy

68 Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor–Based Antiretroviral Therapy

69 CD4+ Cell Count, Viral Load, and Highly Active Antiretroviral Therapy Use Are Independent Predictors of Body Composition Alterations in HIV-Infected Adults: A Longitudinal Study

70 Recurrence and Occurrence of Kaposi’s Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia

71 Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy

72 Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe

73 Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

74 Advanced HIV Disease at Entry into HIV Care and Initiation of Antiretroviral Therapy During 2006–2011: Findings From Four Sub-Saharan African Countries

75 Strengthening Healthcare Capacity Through a Responsive, Country-Specific, Training Standard: The KITSO AIDS Training Programâs Sup-port of Botswanaâs National Antiretroviral Therapy Rollout

76 Randomized Study of the Safety and Efficacy of Fish Oil (Omega-3 Fatty Acid) Supplementation with Dietary and Exercise Counseling for the Treatment of Antiretroviral Therapy—Associated Hypertriglyceridemia

77 Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe

78 Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies

79 Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007

80 Long-Term Effectiveness of Highly Active Antiretroviral Therapy on the Survival of Children and Adolescents with HIV Infection: A 10-Year Follow-Up Study

81 Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries

82 Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and re-vaccination

83 Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

84 Dyslipidemia among HIV-infected Patients with Tuberculosis Taking Once-daily Nonnucleoside Reverse-Transcriptase Inhibitor–Based Antiretroviral Therapy in India

85 Long-Term Effects of Highly Active Antiretroviral Therapy on CD4+ Cell Evolution among Children and Adolescents Infected with HIV: 5 Years and Counting

86 Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa

87 Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

88 Efficacy of Antiretroviral Therapy in Resource-Poor Settings: Are Outcomes Comparable to Those in the Developed World?

89 Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12-month cohort study in urban South Africa and rural Uganda

90 Early Mortality in Adults Initiating Antiretroviral Therapy (ART) in Low- and Middle-Income Countries (LMIC): A Systematic Review and Meta-Analysis

91 Effect of Maintaining Highly Active Antiretroviral Therapy on AIDS Events among Patients with Late-Stage HIV Infection and Inadequate Response to Therapy

92 A Randomized Trial of Ready-to-Use Supplementary Food Versus Corn-Soy Blend Plus as Food Rations for HIV-Infected Adults on Antiretroviral Therapy in Rural Haiti

93 Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

94 Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis

95 a first-line antiretroviral therapy-resistant hiv patient with rhinoentomophthoromycosis

96 electronic medication monitoring-informed counselling to improve adherence to combination antiretroviral therapy and virologic treatment outcomes: a meta-analysis

97 2007 clinical guidelines an antiretroviral therapy management for displaced persons

98 acceptability of bone antiresorptive therapy among hiv-infected adults at different stages of antiretroviral therapy

99 monitoring of therapy in patients with hiv/hcv co-infection who receive antiviral therapy against hepatitis c and antiretroviral therapy

100 access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death

101 the prevalence and incidence of diabetes mellitus and other disorders of glycaemia in south african black patients on antiretroviral therapy

Keyword Connections

Journals

Research Groups

Bibliographies